| UniProt ID | GDAP1_HUMAN | |
|---|---|---|
| UniProt AC | Q8TB36 | |
| Protein Name | Ganglioside-induced differentiation-associated protein 1 | |
| Gene Name | GDAP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 358 | |
| Subcellular Localization |
Mitochondrion outer membrane Multi-pass membrane protein . Cytoplasm . |
|
| Protein Description | Regulates the mitochondrial network by promoting mitochondrial fission.. | |
| Protein Sequence | MAERQEEQRGSPPLRAEGKADAEVKLILYHWTHSFSSQKVRLVIAEKALKCEEHDVSLPLSEHNEPWFMRLNSTGEVPVLIHGENIICEATQIIDYLEQTFLDERTPRLMPDKESMYYPRVQHYRELLDSLPMDAYTHGCILHPELTVDSMIPAYATTRIRSQIGNTESELKKLAEENPDLQEAYIAKQKRLKSKLLDHDNVKYLKKILDELEKVLDQVETELQRRNEETPEEGQQPWLCGESFTLADVSLAVTLHRLKFLGFARRNWGNGKRPNLETYYERVLKRKTFNKVLGHVNNILISAVLPTAFRVAKKRAPKVLGTTLVVGLLAGVGYFAFMLFRKRLGSMILAFRPRPNYF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 11 | Phosphorylation | RQEEQRGSPPLRAEG HHHHHCCCCCCCHHC | 26.07 | 23401153 | |
| 19 | Ubiquitination | PPLRAEGKADAEVKL CCCCHHCCCCHHHEE | 34.30 | 32142685 | |
| 45 | Ubiquitination | QKVRLVIAEKALKCE CCEEEEEEHHHHCCC | 12.54 | 24816145 | |
| 47 | Ubiquitination | VRLVIAEKALKCEEH EEEEEEHHHHCCCCC | 50.42 | 32142685 | |
| 50 | Ubiquitination | VIAEKALKCEEHDVS EEEHHHHCCCCCCCC | 44.45 | 25621951 | |
| 63 | Ubiquitination | VSLPLSEHNEPWFMR CCCCCCCCCCCCEEE | 40.35 | 27667366 | |
| 64 | Ubiquitination | SLPLSEHNEPWFMRL CCCCCCCCCCCEEEC | 53.63 | 22817900 | |
| 79 | Ubiquitination | NSTGEVPVLIHGENI CCCCCCCEEECCCCE | 10.68 | 22817900 | |
| 81 | Ubiquitination | TGEVPVLIHGENIIC CCCCCEEECCCCEEE | 3.90 | 22817900 | |
| 84 | Ubiquitination | VPVLIHGENIICEAT CCEEECCCCEEEEHH | 30.97 | 22817900 | |
| 86 | Ubiquitination | VLIHGENIICEATQI EEECCCCEEEEHHHH | 3.12 | 32142685 | |
| 94 | Ubiquitination | ICEATQIIDYLEQTF EEEHHHHHHHHHHHC | 1.73 | 33845483 | |
| 97 | Ubiquitination | ATQIIDYLEQTFLDE HHHHHHHHHHHCCCC | 3.31 | 23503661 | |
| 98 | Ubiquitination | TQIIDYLEQTFLDER HHHHHHHHHHCCCCC | 41.15 | 32142685 | |
| 104 (in isoform 2) | Ubiquitination | - | 61.68 | - | |
| 104 | Ubiquitination | LEQTFLDERTPRLMP HHHHCCCCCCCCCCC | 61.68 | 27667366 | |
| 105 | Ubiquitination | EQTFLDERTPRLMPD HHHCCCCCCCCCCCC | 50.09 | 22817900 | |
| 105 (in isoform 2) | Ubiquitination | - | 50.09 | - | |
| 113 | Ubiquitination | TPRLMPDKESMYYPR CCCCCCCHHHCCCCC | 45.90 | 24816145 | |
| 114 | Ubiquitination | PRLMPDKESMYYPRV CCCCCCHHHCCCCCH | 48.39 | 32142685 | |
| 120 (in isoform 2) | Ubiquitination | - | 25.30 | - | |
| 120 | Ubiquitination | KESMYYPRVQHYREL HHHCCCCCHHHHHHH | 25.30 | 22817900 | |
| 122 (in isoform 2) | Ubiquitination | - | 29.22 | - | |
| 122 | Ubiquitination | SMYYPRVQHYRELLD HCCCCCHHHHHHHHH | 29.22 | 22817900 | |
| 125 | Ubiquitination | YPRVQHYRELLDSLP CCCHHHHHHHHHCCC | 26.43 | 22817900 | |
| 127 | Ubiquitination | RVQHYRELLDSLPMD CHHHHHHHHHCCCCC | 4.81 | 32142685 | |
| 130 | Ubiquitination | HYRELLDSLPMDAYT HHHHHHHCCCCCCCC | 34.05 | 32142685 | |
| 132 | Ubiquitination | RELLDSLPMDAYTHG HHHHHCCCCCCCCCC | 23.66 | 30230243 | |
| 135 | Ubiquitination | LDSLPMDAYTHGCIL HHCCCCCCCCCCCCC | 12.60 | 33845483 | |
| 135 (in isoform 2) | Ubiquitination | - | 12.60 | - | |
| 135 | Acetylation | LDSLPMDAYTHGCIL HHCCCCCCCCCCCCC | 12.60 | 19608861 | |
| 137 | Ubiquitination | SLPMDAYTHGCILHP CCCCCCCCCCCCCCC | 17.32 | 32142685 | |
| 138 | Ubiquitination | LPMDAYTHGCILHPE CCCCCCCCCCCCCCC | 19.22 | 23503661 | |
| 139 | Ubiquitination | PMDAYTHGCILHPEL CCCCCCCCCCCCCCC | 7.74 | 32142685 | |
| 139 (in isoform 2) | Ubiquitination | - | 7.74 | - | |
| 145 | Ubiquitination | HGCILHPELTVDSMI CCCCCCCCCCHHHCC | 46.45 | 33845483 | |
| 146 | Ubiquitination | GCILHPELTVDSMIP CCCCCCCCCHHHCCC | 7.15 | 23503661 | |
| 146 (in isoform 2) | Ubiquitination | - | 7.15 | - | |
| 149 | Ubiquitination | LHPELTVDSMIPAYA CCCCCCHHHCCCHHH | 27.53 | 32142685 | |
| 162 | Phosphorylation | YATTRIRSQIGNTES HHHHHHHHHCCCCHH | 24.63 | 29214152 | |
| 167 | Phosphorylation | IRSQIGNTESELKKL HHHHCCCCHHHHHHH | 35.36 | 28857561 | |
| 172 | Ubiquitination | GNTESELKKLAEENP CCCHHHHHHHHHHCC | 41.51 | 21906983 | |
| 172 | Ubiquitination | GNTESELKKLAEENP CCCHHHHHHHHHHCC | 41.51 | 21906983 | |
| 173 | Ubiquitination | NTESELKKLAEENPD CCHHHHHHHHHHCCC | 66.60 | 21906983 | |
| 173 | Ubiquitination | NTESELKKLAEENPD CCHHHHHHHHHHCCC | 66.60 | 21906983 | |
| 175 | Ubiquitination | ESELKKLAEENPDLQ HHHHHHHHHHCCCHH | 30.82 | 27667366 | |
| 188 | Ubiquitination | LQEAYIAKQKRLKSK HHHHHHHHHHHHHHH | 46.96 | 21906983 | |
| 188 | Ubiquitination | LQEAYIAKQKRLKSK HHHHHHHHHHHHHHH | 46.96 | 21906983 | |
| 190 | Ubiquitination | EAYIAKQKRLKSKLL HHHHHHHHHHHHHCC | 60.02 | 25621951 | |
| 193 | Ubiquitination | IAKQKRLKSKLLDHD HHHHHHHHHHCCCCH | 49.96 | 22817900 | |
| 195 | Ubiquitination | KQKRLKSKLLDHDNV HHHHHHHHCCCCHHH | 52.02 | 32142685 | |
| 203 | Acetylation | LLDHDNVKYLKKILD CCCCHHHHHHHHHHH | 51.63 | 19608861 | |
| 203 | Ubiquitination | LLDHDNVKYLKKILD CCCCHHHHHHHHHHH | 51.63 | 33845483 | |
| 204 | Phosphorylation | LDHDNVKYLKKILDE CCCHHHHHHHHHHHH | 21.33 | 22817900 | |
| 206 | Ubiquitination | HDNVKYLKKILDELE CHHHHHHHHHHHHHH | 34.38 | 25621951 | |
| 207 | Ubiquitination | DNVKYLKKILDELEK HHHHHHHHHHHHHHH | 46.00 | 32142685 | |
| 214 | Ubiquitination | KILDELEKVLDQVET HHHHHHHHHHHHHHH | 61.80 | 25621951 | |
| 269 | Ubiquitination | GFARRNWGNGKRPNL HHHHCCCCCCCCCCH | 36.24 | 24816145 | |
| 270 | Ubiquitination | FARRNWGNGKRPNLE HHHCCCCCCCCCCHH | 44.41 | 22817900 | |
| 271 | Ubiquitination | ARRNWGNGKRPNLET HHCCCCCCCCCCHHH | 24.34 | 22817900 | |
| 286 | Ubiquitination | YYERVLKRKTFNKVL HHHHHHCHHHHHHHH | 38.80 | 22817900 | |
| 287 | Acetylation | YERVLKRKTFNKVLG HHHHHCHHHHHHHHH | 56.75 | 26051181 | |
| 288 | Ubiquitination | ERVLKRKTFNKVLGH HHHHCHHHHHHHHHH | 36.15 | 22817900 | |
| 291 | Ubiquitination | LKRKTFNKVLGHVNN HCHHHHHHHHHHHHH | 34.35 | 22817900 | |
| 293 | Ubiquitination | RKTFNKVLGHVNNIL HHHHHHHHHHHHHHH | 4.13 | 23503661 | |
| 301 | Ubiquitination | GHVNNILISAVLPTA HHHHHHHHHHHHHHH | 1.89 | 23503661 | |
| 304 | Ubiquitination | NNILISAVLPTAFRV HHHHHHHHHHHHHHH | 5.41 | 23503661 | |
| 305 | Ubiquitination | NILISAVLPTAFRVA HHHHHHHHHHHHHHH | 2.89 | 23503661 | |
| 312 | Ubiquitination | LPTAFRVAKKRAPKV HHHHHHHHHHHCCHH | 13.85 | 23503661 | |
| 322 | Phosphorylation | RAPKVLGTTLVVGLL HCCHHHCHHHHHHHH | 16.88 | 22210691 | |
| 323 | Phosphorylation | APKVLGTTLVVGLLA CCHHHCHHHHHHHHH | 18.76 | 22210691 | |
| 328 | Ubiquitination | GTTLVVGLLAGVGYF CHHHHHHHHHHHHHH | 1.68 | 22817900 | |
| 329 | Ubiquitination | TTLVVGLLAGVGYFA HHHHHHHHHHHHHHH | 2.99 | 22817900 | |
| 344 | Ubiquitination | FMLFRKRLGSMILAF HHHHHHHHCCHHHEE | 7.17 | 22817900 | |
| 346 | Ubiquitination | LFRKRLGSMILAFRP HHHHHHCCHHHEECC | 13.77 | 22817900 | |
| 346 | Phosphorylation | LFRKRLGSMILAFRP HHHHHHCCHHHEECC | 13.77 | 20068231 | |
| 349 | Ubiquitination | KRLGSMILAFRPRPN HHHCCHHHEECCCCC | 2.49 | 22817900 | |
| 351 | Ubiquitination | LGSMILAFRPRPNYF HCCHHHEECCCCCCC | 11.22 | 23503661 | |
| 359 | Ubiquitination | RPRPNYF-------- CCCCCCC-------- | 23503661 | ||
| 362 | Ubiquitination | PNYF----------- CCCC----------- | 23503661 | ||
| 363 | Ubiquitination | NYF------------ CCC------------ | 23503661 | ||
| 370 | Ubiquitination | ------------------- ------------------- | 23503661 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GDAP1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GDAP1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GDAP1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FIS1_HUMAN | FIS1 | physical | 21890626 | |
| TBB5_HUMAN | TUBB | physical | 21890626 | |
| HBB_HUMAN | HBB | physical | 22939629 | |
| SAP_HUMAN | PSAP | physical | 22939629 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 214400 | Charcot-Marie-Tooth disease 4A (CMT4A) | |||||
| 607706 | Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive (CMT2RV) | |||||
| 607831 | Charcot-Marie-Tooth disease 2K (CMT2K) | |||||
| 608340 | Charcot-Marie-Tooth disease, recessive, intermediate type, A (CMTRIA) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-203, AND MASS SPECTROMETRY. | |